We’re very grateful to the Hugo Charitable Trust for their generous donation of $1 million towards our phase II clinical trial on our new treatment for glioblastoma. Glioblastoma is a severe, usually fatal, brain cancer. The Trust’s donation brings us significantly closer to starting the trial.
Dr Matt Munro is developing colon organoids to test the effectiveness of possible treatments for colon cancers. The human organoids are miniature ‘organs in a dish’, created from human tissue samples. Organoids could one day be used routinely to test new treatments and customise treatment for individual patients to improve their outcomes.
Our ambassadors go up mountains, around countries, and push themselves really hard — for our cause, and for New Zealanders who may face brain cancer. These three stories show how wonderful people selflessly raise awareness of our research and the funding it needs. We cherish these three supporters, their amazing stories, and the many other special people who support and inspire us.
We congratulate Erin Paterson, who has been promoted to her new role as Laboratory Manager/Senior Laboratory Technician. Erin’s been at the GMRI since 2017. Over the years she’s been responsible for coordinating the cell culture programme for the GMRI tissue bank, which is vital to our research.
We welcome Freya Weth, who’s joining us for the next three years to complete her PhD in biomedical science. She’s received the Graham Langridge Scholarship and was ‘in complete disbelief’ when she heard the news.